Search results
Results from the WOW.Com Content Network
Rivaroxaban, sold under the brand name Xarelto among others, is an anticoagulant medication (blood thinner) used to treat and prevent blood clots. [8] Specifically it is used to treat deep vein thrombosis and pulmonary emboli and prevent blood clots in atrial fibrillation and following hip or knee surgery. [ 8 ]
This is a list of drugs and substances that are known or suspected to cause Stevens–Johnson syndrome This is a dynamic list and may never be able to satisfy particular standards for completeness. You can help by adding missing items with reliable sources .
Alcohol intoxication can cause blurred vision. Use of cycloplegic drugs like atropine [4] or other anticholinergics cause visual blur due to paralysis of accommodation. [3] Cataracts: Cloudiness over the eye's lens, cause blurring of vision, halos around lights, and sensitivity to glare. [5] It is also the main cause of blindness worldwide. [2]
The Food and Drug Administration compiled a list of over-the-counter eye drops to avoid. 27 eye drops from retailers in California can cause vision loss, FDA warns. See the recall
There are many diseases known to cause ocular or visual changes. Diabetes , for example, is the leading cause of new cases of blindness in those aged 20–74, with ocular manifestations such as diabetic retinopathy and macular edema affecting up to 80% of those who have had the disease for 15 years or more.
Malignant hypertension can cause ischemia of the optic nerve head leading to transient monocular visual loss. [32] Drug abuse-related intravascular emboli [8] Iatrogenic: Amaurosis fugax can present as a complication following carotid endarterectomy, carotid angiography, cardiac catheterization, and cardiac bypass. [29]
Life in quarantine can be tough on the eyes. Since early March, the average U.S. household is also watching about nine more hours of TV a week than before — with viewership rising from about 57 ...
Health officials in Europe are investigating Ozempic and the trendy drug’s possible link to an eye-rotting condition that causes blindness. On Dec. 17, the European Medicines Agency announced ...